Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)

NCT06664866 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.

NCT NCT06664866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06664866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
Lead sponsor
Cedars-Sinai Medical Center
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
October 28, 2024
Completion date
November 1, 2027
Enrollment
500 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac amyloidosis